NCT02163681|CompletedResults
MRI for Non-Invasive Imaging in Neonates and Children
MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Young Children
Loading search results
MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Young Children
Sponsor study identifier
interventional
45
1 country
1
Study Start
January 1, 2011
Actual (reported)Primary Completion
June 30, 2018
Actual (reported)Study Completion
July 30, 2018
Actual (reported)The purpose of this study is to develop rapid MRI techniques for imaging the lung with hyperpolarized helium-3 gas as an inhaled contrast agent. These techniques will be piloted in adults and older children before testing them in younger children and infants. The purpose is to enable imaging of non-sedated infants by imaging so fast as to freeze motion.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2011
Actual (reported)June 10, 2014
Actual (reported)June 16, 2014
Actual (reported)June 30, 2018
Actual (reported)July 30, 2018
Actual (reported)April 19, 2022
Actual (reported)Ventilation Defects as Seen on Hyperpolarized Helium-3 MRI
On hyperpolarized helium-3 MRI, well ventilated areas of the lung appear bright and poorly ventilated areas appear dark. The poorly ventilated areas are called ventilation defects. Human readers looked at the hyperpolarized helium-3 MR images and determined whether the lungs had: No Defects, Small Defects, or Large Defects.
Day 1
Using hyperpolarized helium-3 as an inhaled contrast agent for MRI, we will assess the lung ventilation.
hyperpolarized helium-3 is an inhaled gaseous contrast agent for MRI and permits the acquisition of high quality imagined of lung ventilation.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
Yun M Shim, MD
University of Virginia
45 participants (actual enrollment reported by the registry).
First Submitted
June 10, 2014
First Posted
June 16, 2014
Study Start
January 1, 2011
Actual (reported)Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2018
Actual (reported)Study Completion
July 30, 2018
Actual (reported)Last Updated
April 19, 2022
Results First Posted
April 19, 2022
Record last verified: 2022-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: